TRPA1 as Target in Myocardial Infarction
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032516 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Clara Hoebart und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: Transient Receptor Potential Channels, Myocardial Infarction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FWF Austrian Science Fund, Austrian Science Fund (FWF).
Abstract (Originalsprache)
Transient receptor potential cation channel subfamily A member 1 (TRPA1), an ion channel primarily expressed on sensory neurons, can be activated by substances occurring during myocardial infarction. Aims were to investigate whether activation, inhibition, or absence of TRPA1 affects infarcts and to explore underlying mechanisms. In the context of myocardial infarction, rats received a TRPA1 agonist, an antagonist, or vehicle at different time points, and infarct size was assessed. Wild type and TRPA1 knockout mice were also compared in this regard. In vitro, sensory neurons were co-cultured with cardiomyocytes and subjected to a model of ischemia-reperfusion. Although there was a difference between TRPA1 activation or inhibition in vivo, no experimental group was different to control animals in infarct size, which also applies to animals lacking TRPA1. In vitro, survival probability of cardiomyocytes challenged by ischemia-reperfusion increased from 32.8% in absence to 45.1% in presence of sensory neurons, which depends, at least partly, on TRPA1. This study raises doubts about whether TRPA1 is a promising target to reduce myocardial damage within a 24 h period. The results are incompatible with relevant enlargements of infarcts by TRPA1 activation or inhibition, which argues against adverse effects when TRPA1 is targeted for other indications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.
- Center for Biomedical Research and Translational Surgery, Medical University of Vienna, 1090 Vienna, Austria.
ORCID-Profile: Clara Hoebart, Attila Kiss, Patrick M Pilz, Petra L Szabo, Bruno K Podesser, Michael J M Fischer, Stefan Heber
Förderung
- FWF Austrian Science Fund
- Austrian Science Fund (FWF)
Zitieren
APA
Hoebart, C., Kiss, A., Pilz, P. M., Szabo, P. L., Podesser, B. K., Fischer, M. J. M., & Heber, S. (2023). TRPA1 as Target in Myocardial Infarction. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032516
Vancouver
Hoebart C, Kiss A, Pilz PM, Szabo PL, Podesser BK, Fischer MJM, et al. TRPA1 as Target in Myocardial Infarction. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032516
BibTeX
@article{Hoebart2023,
author = {Hoebart, Clara and Kiss, Attila and Pilz, Patrick M and Szabo, Petra L and Podesser, Bruno K and Fischer, Michael J M and Heber, Stefan},
title = {TRPA1 as Target in Myocardial Infarction},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032516}
}
EUVIMED